Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate

Go back to Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
(NASDAQ: MDCX) Delayed: 0.42 -0.04 (8.7%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 1,714,695       

(NASDAQ: MDCX) Delayed: 0.42 -0.04 (8.7%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 1,714,695